{
    "Trade/Device Name(s)": [
        "ARCHITECT\u00ae Insulin Calibrators",
        "ARCHITECT\u00ae Insulin Controls"
    ],
    "Submitter Information": "Denka Seiken Co., Ltd.",
    "510(k) Number": "K060359",
    "Predicate Device Reference 510(k) Number(s)": [
        "K021535",
        "K030452"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "April 14, 2006",
    "Summary Letter Received Date": "March 2, 2006",
    "Submission Date": "February 2, 2006",
    "Regulation Number(s)": [
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Calibrator"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "endocrine"
    ],
    "Analyte(s)": [
        "Insulin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT\u00ae i System"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent Microparticle Immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Direct, quantitative immunoassay"
    ],
    "Submission Type(s)": [
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT\u00ae Insulin Calibrators and Controls for use with quantitative determination of human insulin on the ARCHITECT\u00ae i System.",
    "Indications for Use Summary": "Calibrators for calibration and controls for verification of accuracy and precision of the ARCHITECT\u00ae i System when used to quantitatively determine human insulin in human serum or plasma.",
    "fda_folder": "Clinical Chemistry"
}